CX Institutional’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $186K | Buy |
1,948
+82
| +4% | +$7.87K | 0.01% | 757 |
|
|
2026
Q1 | $193K | Buy |
1,866
+142
| +8% | +$16.1K | 0.01% | 731 |
|
|
2025
Q4 | $174K | Sell |
1,724
-1,952
| -53% | -$212K | 0.01% | 748 |
|
|
2025
Q3 | $453K | Buy |
3,676
+808
| +28% | +$100K | 0.01% | 457 |
|
|
2025
Q2 | $344K | Sell |
2,868
-96
| -3% | -$12.8K | 0.01% | 467 |
|
|
2025
Q1 | $436K | Buy |
2,964
+136
| +5% | +$20.8K | 0.02% | 401 |
|
|
2024
Q4 | $459K | Buy |
2,828
+51
| +2% | +$8.34K | 0.02% | 355 |
|
|
2024
Q3 | $452K | Buy |
2,777
+35
| +1% | +$5.19K | 0.02% | 380 |
|
|
2024
Q2 | $374K | Buy |
2,742
+9
| +0.3% | +$1.25K | 0.02% | 409 |
|
|
2024
Q1 | $418K | Buy |
2,733
+11
| +0.4% | +$1.64K | 0.02% | 387 |
|
|
2023
Q4 | $388K | Buy |
2,722
+35
| +1% | +$4.67K | 0.02% | 359 |
|
|
2023
Q3 | $352K | Sell |
2,687
-232
| -8% | -$35.3K | 0.02% | 370 |
|
|
2023
Q2 | $464K | Buy |
2,919
+42
| +1% | +$6.77K | 0.02% | 352 |
|
|
2023
Q1 | $451K | Buy |
2,877
+769
| +36% | +$115K | 0.02% | 356 |
|
|
2022
Q4 | $296K | Buy |
2,108
+329
| +18% | +$46.7K | 0.02% | 430 |
|
|
2022
Q3 | $228K | Buy |
1,779
+40
| +2% | +$5.77K | 0.02% | 428 |
|
|
2022
Q2 | $245K | Sell |
1,739
-1,708
| -50% | -$244K | 0.02% | 406 |
|
|
2022
Q1 | $479K | Buy |
3,447
+1,259
| +58% | +$193K | 0.04% | 276 |
|
|
2021
Q4 | $381K | Sell |
2,188
-1,476
| -40% | -$246K | 0.03% | 264 |
|
|
2021
Q3 | $607K | Sell |
3,664
-7,585
| -67% | -$1.31M | 0.05% | 237 |
|
|
2021
Q2 | $2.02M | Buy |
11,249
+54
| +0.5% | +$9.86K | 0.17% | 149 |
|
|
2021
Q1 | $2.16M | Buy |
11,195
+9,188
| +458% | +$1.77M | 0.19% | 132 |
|
|
2020
Q4 | $405K | Sell |
2,007
-37
| -2% | -$7.66K | 0.04% | 245 |
|
|
2020
Q3 | $430K | Buy |
2,044
+22
| +1% | +$4.9K | 0.05% | 213 |
|
|
2020
Q2 | $444K | Buy |
2,022
+85
| +4% | +$17K | 0.06% | 203 |
|
|
2020
Q1 | $336K | Sell |
1,937
-11
| -0.6% | -$1.82K | 0.05% | 197 |
|
|
2019
Q4 | $299K | Sell |
1,948
-49
| -2% | -$7.32K | 0.05% | 175 |
|
|
2019
Q3 | $303K | Buy |
+1,997
| New | +$316K | 0.05% | 193 |
|
|
2019
Q2 | – | Sell |
-1,959
| Closed | -$314K | – | 953 |
|
|
2019
Q1 | $314K | Buy |
1,959
+359
| +22% | +$55.7K | 0.06% | 176 |
|
|
2018
Q4 | $247K | Buy |
+1,600
| New | +$249K | 0.05% | 156 |
|
Other funds holding CLX
CX Institutional's CLX Position: Q2 2026 in Review
CX Institutional increased its Clorox (CLX) stake by 4.4% in Q2 2026, buying an estimated $7.87K and bringing the position to 1,948 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #757.
CX Institutional first reported a position in CLX in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.16M in Q1 2021. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- CX Institutional held 1,948 shares of Clorox worth $186K as of Q2 2026.
- CX Institutional bought 82 Clorox shares in Q2 2026, an estimated $7.87K.
- Clorox made up 0.01% of CX Institutional's portfolio in Q2 2026, its #757 holding.
- CX Institutional first reported a position in Clorox in Q4 2018 and has held it in 30 quarters since.
- CX Institutional's Clorox position peaked at $2.16M in Q1 2021.
- 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.